Resonance Energy Transfer Based Detection of Nosocomial Infection

• US 20090156942A1
• Filed: 12/12/2007
• Published: 06/18/2009
• Est. Priority Date: 12/12/2007
• Status: Active Grant

• Current Assignee: Avent Incorporated (Avanos Medical, Inc.)
• Original Assignee: Kimberly-Clark Worldwide Incorporated (Kimberly-Clark Corporation)
• Inventors: Presley, Talbot, Phillips, Erica M., Rainone, Mike, Baird, Daniel, Plowman, Thomas Edward, Hantke, Richard
• Granted Patent: US 8,180,421 B2
• Time in Patent Office: Days
• US Class Current: 600/478
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/445 Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
• CPC Class Codes: C12Q 1/04 Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor C12Q1/6897 takes precedence
• CPC Class Codes: C12Q 1/37 involving peptidase or proteinase
• CPC Class Codes: C12Q 1/66 involving luciferase
• CPC Class Codes: G01N 2021/6441 with two or more labels
• CPC Class Codes: G01N 2021/7716 in cladding
• CPC Class Codes: G01N 2021/772 Tip coated light guide
• CPC Class Codes: G01N 2021/773 Porous polymer jacket; Polymer matrix with indicator
• CPC Class Codes: G01N 21/6428 Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" in vivo A61B5/00; immunoassay G01N33/53
• CPC Class Codes: G01N 21/648 using evanescent coupling or surface plasmon coupling for the excitation of fluorescence
• CPC Class Codes: G01N 21/7703 using reagent-clad optical fibres or optical waveguides using measurement of total internal reflection or attenuated total reflection G01N21/552; optical fibres or waveguides per se G02B
• CPC Class Codes: G01N 2201/0221 Portable; cableless; compact; hand-held

Abstract

Disclosed herein are methods and devices for detection of hospital acquired infections. Disclosed methods may be utilized for continuous in vivo monitoring of a potential infection site or for periodic in vitro monitoring of tissue or fluid from a patient and may be utilized to alert patients and/or health care providers to the presence of a pathogen at an early stage of infection. Disclosed methods utilize fluorophore pairs that optically interact with one another according to Forster resonance energy transfer (FRET) or bioluminescence resonance energy transfer (BRET) mechanism. One member of the pair or a cofactor that interacts with an enzyme to form a member of the pair may be tethered to a device by a substrate that is specific for an enzyme expressed by a targeted pathogen. Upon interaction of the enzyme with the substrate, an optically detectable signal may be altered or initiated, detection of which may then provide information as to the existence of the pathogen at the site.

Claims

1. A method for detecting the presence or amount of a pathogen that is a source of a hospital acquired infection comprising:

locating an optical fiber in an environment, the optical fiber having directly or indirectly attached thereto a first group of molecules at a site that is within the evanescent field of the core of the optical fiber, the first group of molecules including an acceptor molecule, one of the molecules of the group being attached to the optical fiber with a first tether, the first tether comprising a substrate for an enzyme that is expressed by the pathogen;

transmitting an excitation signal to the site via the optical fiber, the excitation signal comprising an excitation wavelength specific for a donor molecule;

cleaving the substrate by action of the enzyme that is expressed by the pathogen;

transmitting an optically detectable emission signal from the site following the step of cleaving the substrate by action of the enzyme; and

determining the presence or amount of the pathogen in the environment.

2. The method according to claim 1, wherein the group of molecules includes the donor molecule.

3. The method according to claim 2, wherein the acceptor molecule is attached to the optical fiber with the first tether.

4. The method according to claim 1, further comprising degrading a matrix, the matrix encapsulating the group of molecules.

5. The method according to claim 4, wherein the matrix is a polymeric matrix.

6. The method according to claim 1, wherein the environment is an in vivo environment.

7. The method according to claim 1, wherein the environment is a surgical site.

8. The method according to claim 1, further comprising converting the optically detectable emission signal to an electromagnetic signal.

9. The method according to claim 8, further comprising transmitting the electromagnetic signal to a receiver.

10. The method according to claim 9, wherein the electromagnetic signal is transmitted to the receiver according to a wireless transmission system.

11. The method according to claim 1, wherein the optical fiber is a first fiber in a multi-fiber cable, the cable further comprising a second optical fiber.

12. The method according to claim 11, the second optical fiber having attached thereto a second group of molecules at a site that is within the evanescent field of the core of the second optical fiber, the second group of molecules including a second acceptor molecule, one of the second group of molecules being attached to the second optical fiber with a second tether, the second tether comprising a substrate for an enzyme that is expressed by a pathogen that is a source of hospital acquired infection, the method further comprising transmitting a second excitation signal to the second group of molecules via the second optical fiber.

13. The method according to claim 12, wherein the first excitation signal is transmitted via the first optical fiber and the second excitation signal is transmitted via second optical fiber sequentially.

14. The method according to claim 1, the group of molecules further comprising a second enzyme and a molecular cofactor, wherein one of the second enzyme and the molecular cofactor is attached to the optical fiber with the first tether, the method further comprising interacting the molecular cofactor with the second enzyme following cleavage of the substrate, wherein interaction between the molecular cofactor and the second enzyme generates a donor molecule at an excited state.

15. A portable device for detecting the presence or amount of a pathogen that is a source of a hospital acquired infection comprising:

a portable enclosure containing a power source, an excitation source, an optical detector, a signal processor, and a signaling device for emitting a signal upon detection of an enzyme that is expressed by the pathogen;

a connecting device for attaching the enclosure to the clothing or body of a wearer;

a fiber optic cable for inserting into an environment, the fiber optic cable being in optical communication with the optical detector, the fiber optic cable extending for a length exterior to the enclosure, the fiber optic cable comprising an optical fiber; and

a group of molecules directly or indirectly attached to the optical fiber at a site that is within the evanescent field of the core of the optical fiber, the group of molecules including an acceptor molecule, wherein one of the group of molecules is attached to the optical fiber with a tether comprising a substrate for an enzyme that is expressed by the pathogen.

16. The device of claim 15, the group of molecules further comprising a donor molecule.

17. The device of claim 15, the device further comprising a degradable matrix encapsulating the group of molecules.

18. The device of claim 15, wherein the fiber optic cable contains a plurality of optical fibers.

19. The device of claim 15, the portable enclosure further comprising a transmitter in electrical communication with the signaling device, wherein the signal emitted from the signaling device is subsequently transmitted from the transmitter.

20. The device of claim 19, further comprising a receiver, wherein the transmitter is in wireless communication with the receiver.

21. The device of claim 15, wherein the connecting device is for connecting the enclosure to a piece of clothing.

22. The device of claim 15, wherein the connecting device is for connecting the enclosure to a wearer'"'"'s skin.

23. The device of claim 15, wherein the group of molecules is directly attached to a particle.

24. The device of claim 15, further comprising a semi-permeable barrier surrounding at least a portion of the fiber optic cable.

25. The device of claim 15, the group of molecules further comprising a second enzyme and a molecular cofactor.

26. The device of claim 25, wherein the second enzyme is luciferase and the molecular cofactor is luciferin.